[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-351161-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-351161-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","anoikis-resistance-and-metastasis-of-ovarian-cancer-can-be-overcome-by-cdk819-mediator-kinase-inhibition","Anoikis resistance and metastasis of ovarian cancer can be overcome by CDK8/19 mediator kinase inhibition","","Anoikis resistance, the ability of cancer cells to evade death after detachment from the extracellular matrix, drives ovarian cancer survival and metastatic dissemination. Repeated suspension stress followed by recovery under attachment conditions generated a non-genetic, time-limited anoikis-resistant state linked to increased invasion, chemoresistance, and immune evasion in vitro, and distant metastasis in vivo. CDK8/19 mediator kinase inhibition reversed this resistance and induced bidirectional transcriptomic remodeling that disrupts the adaptive transcriptional balance.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/anoikis-resistance-and-metastasis-of-ovarian-cancer-can-be-overcome-by-cdk819-mediator-kinase-inhibition/351161/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/anoikis-resistance-and-metastasis-of-ovarian-cancer-can-be-overcome-by-cdk819-mediator-kinase-inhibition/351161.png","ImageObject",300,407,{"name":42,"@type":43},"Genevieve","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-31","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",5,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is anoikis resistance in ovarian cancer, and why does it matter for metastasis?","Question",{"text":63,"@type":64},"Anoikis resistance is the evasion of cell death triggered by matrix detachment. It supports cancer cell survival during dissemination and is linked to metastasis of ovarian cancers.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was anoikis resistance developed in the study?",{"text":68,"@type":64},"The study used repeated exposure to suspension stress followed by recovery under attached conditions, which led to acquired anoikis resistance.",{"name":70,"@type":61,"acceptedAnswer":71},"What effect does CDK8/19 mediator kinase inhibition have on anoikis resistance and metastasis?",{"text":72,"@type":64},"CDK8/19 inhibition reversed acquired anoikis resistance and also sensitized in vivo metastatic growth of ovarian cancers, offering a therapeutic opportunity to prevent and suppress metastasis.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},351161,1790673651,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,100,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Comic",60,"comic",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},6,"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":55,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},1374391974585,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","RESE AR CH  \nARTICLE  \nAuthorship note: MM and RR contributed equally to this work asco–first authors. MKJ, LI, EW, AS, IBR, EVB, and MC contributed equally to this work.  \nConflict of interest: IBR is the founder and president, MC is the director of research, and EVB is a consultant of Senex Biotechnology, Inc.  \nCopyright: © 2026, Monavarianet al. This is an open access article published under the terms of the Creative Commons Attribution 4.0 International License.  \nSubmitted: February 20, 2025  \nAccepted: January 2, 2026  \nPublished: January 15, 2026  \nReference information: JCI Insight. 2026;11(4):e192113 .  \n[https://doi.org/10.1172/jci](https://doi.org/10.1172/jci). insight.192113 .  \nAnoikis resistance and metastasis of ovarian cancer can be overcome by CDK8/19 mediator kinase inhibition  \nMehri Monavarian,1 Resha Rajkarnikar,1 Emily Faith Page,1 Asha Kumari,1 Liz Quintero Macias,1 Felipe Massicano,2 Nam Y. Lee,3 Sarthak Sahoo,4 Nadine Hempel,5 Mohit Kumar Jolly,4 Lara Ianov,2,6 Elizabeth Worthey,2 Abhyudai Singh,7 Igor B. Roninson,8 Eugenia V. Broude,8 Mengqian Chen,8 and Karthikeyan Mythreye1  \n1Division of Molecular Cellular Pathology, Department of Pathology, O’Neal Cancer Center, Heersink School of Medicine, The University of Alabama, Birmingham, Alabama, USA. 2UAB Biological Data Science Core, The University of Alabama at Birmingham, Birmingham, Alabama, USA. 3Department of Pharmacology, College of Medicine, University of Arizona, Tucson, Arizona, USA. 4Department of Bioengineering, Indian Institute of Science, Bangalore, India. 5Division of Malignant Hematology and Medical Oncology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA. 6Department of Neurobiology, The University of Alabama at Birmingham, Birmingham, Alabama, USA. 7Department of Electrical and Computer Engineering, University of Delaware, Newark, Delaware, USA. 8Department of Drug Discovery and Biomedical Sciences, College of Pharmacy, University of South Carolina, Columbia, South Carolina, USA.  \nAnoikis resistance, or evasion of cell death triggered by matrix detachment, is a hallmark of cancer cell survival and metastasis. We showed that repeated exposure to suspension stress followed by recovery under attached conditions leads to development of anoikis resistance. The acquisition of anoikis resistance was associated with enhanced invasion, chemoresistance, and immune evasion in vitro and distant metastasis in vivo. This acquired anoikis resistance was not genetic, persisting for a finite duration without detachment stress, but was sensitive to CDK8/19 mediator kinase inhibition that could also reverse anoikis resistance. Transcriptomic analysis revealed that CDK8/19 kinase inhibition induces bidirectional transcriptional changes in both sensitive and resistant cells, disrupting the balanced reprogramming required for anoikis adaptation and resistance by reversing some resistance-associated pathways and enhancing others. Both anoikis resistance and in vivo metastatic growth of ovarian cancers are sensitive to CDK8/19 inhibition, thereby providing a therapeutic opportunity to both prevent and suppress ovarian cancer metastasis.  \nIntroduction  \nMetastasis causes most cancer-related deaths, yet metastatic cancers remain largely incurable. A critical step in metastasis is the ability of tumor cells to survive upon detachment from the extracellular matrix and primary tumor site, enabling their dissemination and circulation to distant sites (1–3) . Despite our understanding of these metastatic features, their therapeutic targeting remains underdeveloped.  \nOvarian cancers (OCs), comprising several subtypes, are among the most devastating of gynecological cancers and archetypal examples of cancers that leverage the metastatic hallmark of anoikis resistance for both transcoelomic/i.p. and distant metastasis (4–8) . As malignant ascites accumulates, tumor cells must survive in suspension and evade cell dea","cbCaigV1JqJc0F6c","https://ap.wps.com/l/cbCaigV1JqJc0F6c","pdf",3748582,22,"English","# Introduction\n## Anoikis resistance and metastasis in ovarian cancer\n## Mechanisms and evidence from suspension models\n## Therapeutic rationale for CDK8/19 inhibition","[{\"question\":\"What is anoikis resistance in ovarian cancer, and why does it matter for metastasis?\",\"answer\":\"Anoikis resistance is the evasion of cell death triggered by matrix detachment. It supports cancer cell survival during dissemination and is linked to metastasis of ovarian cancers.\"},{\"question\":\"How was anoikis resistance developed in the study?\",\"answer\":\"The study used repeated exposure to suspension stress followed by recovery under attached conditions, which led to acquired anoikis resistance.\"},{\"question\":\"What effect does CDK8/19 mediator kinase inhibition have on anoikis resistance and metastasis?\",\"answer\":\"CDK8/19 inhibition reversed acquired anoikis resistance and also sensitized in vivo metastatic growth of ovarian cancers, offering a therapeutic opportunity to prevent and suppress metastasis.\"}]","Anoikis resistance and metastasis of ovarian cancer can be overcome by CDK8/19 mediator kinase inhibition | PDF",1790092872,55,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d843c44a4c9b5a03b6ab50fcf94464bb.webp",983,1315,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6c2aab8f0e7ec57e4db51b08b7e1b1cc.webp",982,1314,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a0b93f980db82605e82270efba8ffe17.webp",981,1312,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/42652b89f8a5b62cb642da52a2cf2465.webp",980,1311]